This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Recorded Friday, October 15, 2021
From point A to Z, CLL Society will share which tests you should be advocating for to ensure you are receiving the best possible care.
Join CLL Society for this important Ed Forum to learn the basics about testing across the span of your CLL journey. At the time of diagnosis, find out which tests should be performed, which might be avoided, and why. Before starting your first treatment, and prior to every subsequent treatment, know which tests you absolutely must have, which we strongly advise through CLL Society’s Test Before Treat™ campaign. Two patients will share their stories about the importance of getting the right tests completed prior to choosing treatment. Finally, learn how CLL is monitored over time, and how the evolving role of MRD (measurable residual disease) testing may help determine when to stop therapy in CLL.
Brian Koffman, MDCM (retired)
Brian Koffman, MDCM (retired) MS Ed
Ryan Jacobs, MD
Brian Hill, MD, PhD
This program was made possible by grant support from Adaptive Biotechnologies, Genentech Pharmacyclics, and Janssen.